MLYS - Mineralys Therapeutics, Inc.
28.43
1.190 4.186%
Share volume: 3,587,124
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$27.24
1.19
0.04%
Summary score
37%
Profitability
35%
Dept financing
20%
Liquidity
50%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-12.42%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
21.74%
Debt ratio change over timeo
0%
Current Ratio
17.91%
Quick Ratio
0%
Cash Position Ratio
6.84%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-14.84%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
4.93%
Debt ratio change over timeo
0%
Current Ratio
22%
Quick Ratio
0%
Cash Position Ratio
9.79%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-6.86%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
3.92%
Debt ratio change over time
0%
Current Ratio
25.5%
Quick Ratio
0%
Cash Position Ratio
9.25%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MLYS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 13.23% | 9.84% | 26.17% |
| Return on assets | -12.42% | 4.59% | 3.2% | 1.81% |
| Return on sales | 0% | 30.04% | 25.15% | 24.65% |
| Return on invested capital | 0% | 8.51% | 10.28% | 4.83% |
| Profitability | 0% | 83% | 73% | 67% |
| Total debt ratio | 21.74% | 80.7% | 59.39% | 93.28% |
| Debt ratio change over time | 0% | -16.59% | -73.52% | 21.11% |
| Dept financing | 6% | 22% | 16% | 50% |
| Current Ratio | 22% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 9.79% | 0.14% | 0.46% | 0.15% |
| Liquididy | 50% | 27% | 29% | 21% |
| Short-term ratios | MLYS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -14.84% | 5.82% | 4.08% | 0.78% |
| Return on sales | 0% | 38.27% | 25.36% | 15.48% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 13% |
| Total debt ratio | 4.93% | 81.38% | 59.57% | 99.65% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 26% | 20% | 15% | 25% |
| Current Ratio | 22% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 9.79% | 0.14% | 0.46% | 0.15% |
| Liquididy | 50% | 27% | 23% | 15% |